Results 131 to 140 of about 2,383,060 (385)

Evolutionary Conservation Biology: Introduction [PDF]

, 2004
Evolution has molded the past and paves the future of biodiversity. As anthropogenic damage to the Earth's biota spans unprecedented temporal and spatial scales, it has become urgent to tear down the traditional scientific barriers between conservation ...
Couvet, D., Dieckmann, U., Ferriere, R.
core   +1 more source

The Evolutionary Biology of Chelicerata

Annual Review of Entomology
Chelicerata constitutes an ancient, biodiverse, and ecologically significant group of Arthropoda. The study of chelicerate evolution has undergone a renaissance in the past decade, resulting in major changes to our understanding of the higher-level phylogeny and internal relationships of living orders.
Prashant P, Sharma, Efrat, Gavish-Regev
openaire   +2 more sources

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

Molecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova, Dominika Maurencova, Barbora Salovska, Marek Kratky, Tomas Mracek, Zuzana Korandova, Alena Pecinova, Pavla Vasicova, David Rysanek, Ladislav Andera, Ivo Fabrik, Rudolf Kupcik, Pavel Kashmel, Pinky Sultana, Vojtech Tambor, Jiri Bartek, Josef Novak, Marie Vajrychova, Zdenek Hodny   +18 more
wiley   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

Outlines of Evolutionary Biology [PDF]

, 1923
Arthur Dendy
openalex   +1 more source

Fewer invited talks by women in evolutionary biology symposia

Journal of Evolutionary Biology, 2013
Lower visibility of female scientists, compared to male scientists, is a potential reason for the under‐representation of women among senior academic ranks.
J. Schroeder, H. Dugdale, Reinder Radersma, Martin Hinsch, D. Buehler, J. Saul, Lindsey Porter, A. Liker, Cauwer, P. Johnson, A. W. Santure, A. Griffin, Bolund, Laura Ross, T. J. Webb, P. Feulner, I. Winney, Marta Szulkin, J. Komdeur, Maaike A. Versteegh, C. Hemelrijk, E. Svensson, Hannah A Edwards, M. Karlsson, S. West, Barrett, D. Richardson, V. Brink, J. H. Wimpenny, S. Ellwood, M. Rees, K. Matson, A. Charmantier, dos Remedios, N. A. Schneider, C. Teplitsky, W. Laurance, R. Butlin, Nicholas P. C. Horrocks   +38 more
semanticscholar   +1 more source

Evolutionary Biology: Sterile Saviours [PDF]

Current Biology, 2008
Sterile sperm castes are widespread, but their significance remains enigmatic. New experiments on Drosophila pseudoobscura reveal that sterile sperm may promote the survival of fertilising sperm inside the spermicidal female reproductive tract.
openaire   +4 more sources

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

A Century of Progress in Evolutionary Biology [PDF]

, 1960
W. H. Thorpe
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source